File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Thromboembolic disease in palliative and end-of-life care: A narrative review

TitleThromboembolic disease in palliative and end-of-life care: A narrative review
Authors
KeywordsAnticoagulation
End-of-life care
Palliative care
Thromboprophylaxis
Venous thromboembolism
Issue Date2019
Citation
Thrombosis Research, 2019, v. 175, p. 84-89 How to Cite?
AbstractVenous thromboembolism (VTE) is both common and a potential contributor to symptom burden in patients receiving palliative and end-of-life care. Many of the VTE treatment and prophylaxis recommendations are drawn from data of clinical trials assessing conventional VTE and cancer-associated thrombosis that excluded patients receiving specialist palliative or hospice care. In this group, the epidemiology of VTE and associated outcomes, as well as the risks and benefits of treatment in keeping with a palliative approach are of growing clinical and research interest. This narrative review summarizes current knowledge and challenges in the management of thromboembolic disease in palliative care, highlighting the complexity of decisions surrounding VTE treatment and prophylaxis.
Persistent Identifierhttp://hdl.handle.net/10722/346695
ISSN
2023 Impact Factor: 3.7
2023 SCImago Journal Rankings: 1.098

 

DC FieldValueLanguage
dc.contributor.authorChin-Yee, Nicolas-
dc.contributor.authorTanuseputro, Peter-
dc.contributor.authorCarrier, Marc-
dc.contributor.authorNoble, Simon-
dc.date.accessioned2024-09-17T04:12:39Z-
dc.date.available2024-09-17T04:12:39Z-
dc.date.issued2019-
dc.identifier.citationThrombosis Research, 2019, v. 175, p. 84-89-
dc.identifier.issn0049-3848-
dc.identifier.urihttp://hdl.handle.net/10722/346695-
dc.description.abstractVenous thromboembolism (VTE) is both common and a potential contributor to symptom burden in patients receiving palliative and end-of-life care. Many of the VTE treatment and prophylaxis recommendations are drawn from data of clinical trials assessing conventional VTE and cancer-associated thrombosis that excluded patients receiving specialist palliative or hospice care. In this group, the epidemiology of VTE and associated outcomes, as well as the risks and benefits of treatment in keeping with a palliative approach are of growing clinical and research interest. This narrative review summarizes current knowledge and challenges in the management of thromboembolic disease in palliative care, highlighting the complexity of decisions surrounding VTE treatment and prophylaxis.-
dc.languageeng-
dc.relation.ispartofThrombosis Research-
dc.subjectAnticoagulation-
dc.subjectEnd-of-life care-
dc.subjectPalliative care-
dc.subjectThromboprophylaxis-
dc.subjectVenous thromboembolism-
dc.titleThromboembolic disease in palliative and end-of-life care: A narrative review-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.thromres.2018.12.028-
dc.identifier.pmid30731388-
dc.identifier.scopuseid_2-s2.0-85060919495-
dc.identifier.volume175-
dc.identifier.spage84-
dc.identifier.epage89-
dc.identifier.eissn1879-2472-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats